Skip to Main Content

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, despite mounting anxiety over that coronavirus, because that oh-so-familiar routine of meetings, deadlines, and the like has predictably returned. To cope, yes, we have fired up the coffee kettle and we are brewing cups of stimulation. Our choice today is peppermint mocha, for those of you who are curious. Meanwhile, here are a few items of interest to help you get going. Hope you survive the day and do keep in touch.

AbbVie (ABBV) says China is testing one of its HIV medicines as a treatment for symptoms of the new coronavirus that is rapidly spreading, Reuters writes. Aluvia, which is also known as Kaletra, is a combination of lopinavir and ritonavir. In guidance published last week, the Chinese government said there is no effective anti-virus medicine but suggested taking two Aluvia pills and inhaling a dose of nebulized alpha-interferon twice a day.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!